FdaApplication
NDA 020918
Identifiers
- fda_app_no: NDA020918
Properties
| Property | Value |
|---|---|
| applicant_name | NOVO NORDISK PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1998-06-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLUCAGEN | GLUCAGON HYDROCHLORIDE | EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INTRAMUSCULAR, INTRAVENOUS |
| GLUCAGEN | GLUCAGON HYDROCHLORIDE | EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
2 products